2 1 Shi Ji Jing Ji Bao Dao·2025-09-18 02:17Group 1 - The core viewpoint of the article highlights the significant target price increases for certain listed companies, with Haier Biomedical, Sanlian Hongpu, and Laofengxiang leading the rankings with target price increases of 32.81%, 32.56%, and 30.70% respectively, indicating strong bullish sentiment in the medical device, professional engineering, and jewelry sectors [1] - On September 17, a total of 29 target price adjustments were made by brokerages, reflecting active market engagement and potential investment opportunities [1] - Seven companies received initial coverage from brokerages on the same day, with Zhongfu Industrial and COFCO Sugar both rated "Buy" by Zhongyuan Securities, indicating positive outlooks for these firms [1] Group 2 - Shanshui Technology received a "Buy" rating from Dongbei Securities, suggesting confidence in its growth potential [1] - Heng Rui Pharmaceutical was rated "Buy" by Bohai Securities, reflecting optimism in the pharmaceutical sector [1] - Kaipu Cloud was also rated "Buy" by Zheshang Securities, indicating a favorable view on its market prospects [1]